Cécile Dorange
About
Cécile Dorange is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Cécile Dorange has authored 45 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 20 papers in Pulmonary and Respiratory Medicine and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cécile Dorange's work include Coronary Interventions and Diagnostics (34 papers), Cardiac Imaging and Diagnostics (13 papers) and Cardiac Valve Diseases and Treatments (12 papers). Cécile Dorange is often cited by papers focused on Coronary Interventions and Diagnostics (34 papers), Cardiac Imaging and Diagnostics (13 papers) and Cardiac Valve Diseases and Treatments (12 papers). Cécile Dorange collaborates with scholars based in Netherlands, United States and France. Cécile Dorange's co-authors include Patrick W. Serruys, Yoshinobu Onuma, Susan Veldhof, Leif Thuesen, Héctor M. García‐García, John A. Ormiston, Dariusz Dudek, Bernard Chevalier, Karine Miquel‐Hébert and Evelyn Regar and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.
In The Last Decade
Cécile Dorange
42 papers receiving 3.5k citations
Hit Papers
Peers
Cécile Dorange
Teresio Motta Italy
Takashi Tamura Japan
Kevin A. Raskin United States
Costantino Errani Italy
G. Douglas Letson United States
Marco Alberghini Italy
Marco Perin Brazil
Jean Fajadet France
Emanuela Palmerini Italy
Thomas K. Chung United States
Citations per year, relative to Cécile Dorange Cécile Dorange (= 1×)
peers
Teresio Motta
Countries citing papers authored by Cécile Dorange
Since
Specialization
Citations
This map shows the geographic impact of Cécile Dorange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Dorange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Dorange more than expected).
Fields of papers citing papers by Cécile Dorange
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Cécile Dorange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Dorange. The network helps show where Cécile Dorange may publish in the future.
Co-authorship network of co-authors of Cécile Dorange
This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Dorange. A scholar is included among the top collaborators of Cécile Dorange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Dorange. Cécile Dorange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Peters, Solange, Federico Cappuzzo, Leora Horn, et al.. (2017). OA03.05 Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab vs Docetaxel in CheckMate 057. Journal of Thoracic Oncology. 12(1). S253–S253.
2.
Ott, Patrick A., Emiliano Calvo, Padmanee Sharma, et al.. (2017). Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study. Annals of Oncology. 28. iii139–iii139.
3.
Abizaid, Alexandre, J. Ribamar Costa, Antonio L. Bartorelli, et al.. (2015). The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 10(12). 1396–1401.
4.
Muramatsu, Takashi, Yoshinobu Onuma, Robert‐Jan van Geuns, et al.. (2014). 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds. JACC: Cardiovascular Interventions. 7(5). 482–493.
5.
Şimşek, Cihan, Michael Magro, Yoshinobu Onuma, et al.. (2014). Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH). EuroIntervention. 10(2). 236–240.
6.
Serruys, Patrick W., Yoshinobu Onuma, Héctor M. García‐García, et al.. (2014). Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention. 9(11). 1271–1284.
7.
Bourantas, Christos V., Michail I. Papafaklis, Anna Kotsia, et al.. (2014). Effect of the Endothelial Shear Stress Patterns on Neointimal Proliferation Following Drug-Eluting Bioresorbable Vascular Scaffold Implantation. JACC: Cardiovascular Interventions. 7(3). 315–324.
8.
Gómez‐Lara, Josep, Roberto Diletti, Salvatore Brugaletta, et al.. (2012). Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study. EuroIntervention. 8(2). 214–224.
9.
Grube, Eberhard, Bernard Chevalier, Giulio Guagliumi, et al.. (2012). The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. American Heart Journal. 163(5). 867–875.e1.
10.
Grube, Eberhard, Bernard Chevalier, Peter Smits, et al.. (2011). The SPIRIT V Study. JACC: Cardiovascular Interventions. 4(2). 168–175.
11.
Brugaletta, Salvatore, Josep Gómez‐Lara, Héctor M. García‐García, et al.. (2011). Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. International journal of cardiac imaging. 28(6). 1307–1314.
12.
Sarno, Giovanna, Yoshinobu Onuma, Hector M. Garcia Garcia, et al.. (2010). IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus‐eluting device during the bioabsorption process. Catheterization and Cardiovascular Interventions. 75(6). 914–918.
13.
Gómez‐Lara, Josep, Héctor M. García‐García, Yoshinobu Onuma, et al.. (2010). A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents. JACC: Cardiovascular Interventions. 3(11). 1190–1198.
14.
Gómez‐Lara, Josep, Salvatore Brugaletta, Roberto Diletti, et al.. (2010). A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. European Heart Journal. 32(3). 294–304.
15.
Garg, Scot, Patrick W. Serruys, Yoshinobu Onuma, et al.. (2009). 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions. JACC: Cardiovascular Interventions. 2(12). 1190–1198.
16.
Serruys, Patrick W., John A. Ormiston, Yoshinobu Onuma, et al.. (2009). A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. The Lancet. 373(9667). 897–910.
17.
Khattab, Ahmed A., Gert Richardt, Vitali Verin, et al.. (2008). Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial. EuroIntervention. 3(5). 566–573.
18.
Beijk, Marcel A.M., Franz–Josef Neumann, Marcus Wiemer, et al.. (2007). Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). EuroIntervention. 3(2). 206–212.
19.
Desaga, Martin, Klaus Rasmussen, Harry Suryapranata, et al.. (2007). One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study. EuroIntervention. 3(3). 315–320.
20.
Dawkins, Keith D., Bernard Chevalier, Leif Thuesen, et al.. (2005). Effectiveness of “Direct” Stenting Without Balloon Predilatation (from the Multilink Tetra Randomised European Direct Stent Study [TRENDS]). The American Journal of Cardiology. 97(3). 316–321.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Teresio Motta Breakdown of academic impact, for papers by Takashi Tamura Breakdown of academic impact, for papers by Kevin A. Raskin Breakdown of academic impact, for papers by Costantino Errani Breakdown of academic impact, for papers by G. Douglas Letson Breakdown of academic impact, for papers by Marco Alberghini Breakdown of academic impact, for papers by Marco Perin Breakdown of academic impact, for papers by Jean Fajadet Breakdown of academic impact, for papers by Emanuela Palmerini Breakdown of academic impact, for papers by Thomas K. Chung